{
  "document_info": {
    "file_name": "Example Viking QAP013.01 Risk Management Final.pdf",
    "file_path": "/Users/matthewparson/Desktop/SC/Risk Management/Example Viking QAP013.01 Risk Management Final.pdf",
    "file_size_bytes": 724940,
    "uploaded_file_id": "file-U7TAxfLL8NGe4cQTrSKUJR",
    "content_hash": "45a2637b23af0c79117408aca590af18dc85f965683b9369ce51ca2bd36c6fd7",
    "file_id_cache_hit": true,
    "model": "gpt-5",
    "evaluated_at": "2025-09-25T17:14:03.484612",
    "run_id": "20250925_171403"
  },
  "evaluation_summary": {
    "total_requirements": 3,
    "compliance_score": 66.7,
    "status_counts": {
      "PASS": 2,
      "FAIL": 1,
      "FLAGGED": 0,
      "NOT_APPLICABLE": 0,
      "ERROR": 0
    },
    "total_tokens_used": 61473,
    "estimated_cost_usd": 0.3074
  },
  "requirements_results": [
    {
      "status": "PASS",
      "confidence": 0.89,
      "rationale": "All acceptance criteria are clearly met. A controlled SOP exists with document control metadata and revision history; scope explicitly covers the full product life cycle; the process flow is depicted by Figure 1 and reinforced by a life\u2011cycle list of elements; and the procedure is integrated with related QMS processes (Design Control, Document Control, Management Review, Training, Supplier Management, and Post\u2011Market/Complaint Handling). The SOP defines and implements risk analysis, risk evaluation, risk control, and production/post\u2011production activities, and mandates maintaining a Risk Management File throughout the life cycle.",
      "evidence": [
        "Front matter/header: \"Document Number: QAP013.01 ... Title: RISK MANAGEMENT PROGRAM ... Effective Date: 26Jun2024 ... Subsection: Procedures ... 7. Revision History ... A New Document\"",
        "Section 1.1: \"establish, implement, document and maintain an ongoing process for risk management ... in accordance with ... ISO 14971:2019\"",
        "Section 1.2 (Scope): \"applies ... throughout the product lifecycle phases, including product development, technology and design transfer, manufacturing, product surveillance and product discontinuation.\"",
        "Section 5.1.2: \"Risk management is integrated within QAP012, Design Control as part of product realization.\"",
        "Section 5.1.4: \"The risk management process includes the following elements throughout the product life cycle: ... Identifying hazards and hazardous situations ... Estimating and evaluating the associated risks ... Controlling risk and monitoring the effectiveness ... Risk reviews driven by new information ... Periodic review of identified risks.\"",
        "Section 5.1.5 and Figure 1: \"Figure 1 illustrates the systemic representation of the risk management process.\" [Figure 1. Risk Management Overview diagram present]",
        "Section 5.6 heading and 5.6.1.1: \"Risk Analysis ... Identify all reasonably foreseeable and/or known hazards ... Estimate the probability of the occurrence and severity of the harms ... Identify the risk controls ... Estimate the reduction or elimination ...\"",
        "Section 5.8 heading and 5.8.1: \"Risk Evaluation ... evaluate estimated risks to determine whether the risk is acceptable, using criteria for risk acceptability defined in the risk management plan.\"",
        "Section 5.9 heading and 5.9.1.1\u20135.9.1.2: \"Risk Control ... When risk reduction is required ... Risk reduction shall be achieved by any combination of designing for inherent safety and/or implementation of protective measures.\"",
        "Section 5.12 heading and 5.12.1: \"Production and Post-Production Activities ... Information ... shall be actively collected and reviewed in the production and post-production phases ... Post Market Surveillance and Complaint Handling Process.\"",
        "Section 5.13 heading and 5.13.1: \"Periodic reviews of risk management documentation shall be conducted as a post market activity on an annual basis ...\"",
        "Section 5.3.1: \"a risk management file shall be established and maintained throughout the product lifecycle.\"",
        "Section 5.3.5: \"contents of the risk management file ... shall be controlled and maintained in the document management system in accordance with QAP001\"",
        "Section 5.5.1\u20135.5.3: \"Verification ... Refer to QAP012, Design Control ... Verification that the risk control is effective is conducted in accordance with QAP012\"",
        "Section 5.1.6: \"in accordance with the Management Review Process specified in XX-YYY, Management Responsibility.\"",
        "Section 1.4: \"evaluated and approved in accordance with XX-XXX, Supplier Qualification and Management.\"",
        "Section 5.1.8: \"training program requirements are described in QAP011, GMP Training Program.\"",
        "Section 3 (References): \"Viking QAP012 Design Control\"; \"ISO 14971: 2019\"",
        "Table 6 (Section 5.9.4.3): \"Required Action Based on Residual Risk Evaluation ... Red \u2022 Benefit-risk analysis ... \u2022 Technical analysis ... \u2022 Residual risk disclosure ... Yellow \u2022 Investigate further risk controls ... \u2022 Benefit-risk analysis ... Green \u2022 Overall benefit-risk analysis within the Risk Management Report\""
      ],
      "gaps": [
        "Some QMS cross-references use placeholder numbers (e.g., \"XX-XXX, Supplier Qualification and Management\" and \"XX-YYY, Management Responsibility\").",
        "References list includes a likely typo/outdated entries (\"ISO 12971: 2020\" instead of ISO/TR 24971:2020; \"ISO 62366: 2005\" rather than the current IEC 62366-1 edition).",
        "Figure 1 content is referenced and present, but the diagram text is not fully legible in the provided image; consider ensuring the figure is clearly readable in the controlled PDF."
      ],
      "recommendations": [
        "Replace placeholder QMS document numbers (XX-XXX, XX-YYY) with actual controlled document identifiers and add the specific document number for the Post Market Surveillance and Complaint Handling Process.",
        "Correct and update the References section (use ISO/TR 24971:2020 instead of \"ISO 12971: 2020\"; update usability reference to IEC 62366-1 current edition).",
        "Ensure Figure 1 is high-resolution/legible in the controlled document, or add a text-based flow description alongside the figure to clearly show Risk Analysis, Risk Evaluation, Risk Control, and Production/Post-Production feedback loops.",
        "Optionally add a pointer to the approved Risk Management Plan template/location that contains the risk acceptability criteria to reinforce traceability."
      ],
      "requirement_id": "ISO14971-4.1-01",
      "tokens_used": 22469
    },
    {
      "status": "FAIL",
      "confidence": 0.78,
      "rationale": "Two of three acceptance criteria are addressed procedurally (defined roles; training program references), but there is no explicit evidence of top\u2011management commitment such as management review records or resourcing decisions. The SOP describes that management shall review the process and provide resources, and that records shall be maintained, but no actual management review minutes, approvals, org charts, or resource plans are included.",
      "evidence": [
        "Section 2. Responsibilities: Functional Area Management (Product Development, Clinical Development, Regulatory Affairs and Quality Assurance Management) \u2014 \"Assures adequate resources and support to carry out this process.\" and \"Ensures provision of adequate resources and assignment of competent personnel for risk management\" and \"Reviews suitability of the risk management process at planned intervals... and documents any decisions and actions taken\"",
        "Section 2. Responsibilities: Quality Assurance Management \u2014 \"Overall responsibility for effective execution and oversight of risk management process...\" and \"Overall responsibility for the Quality Management System (QMS), including the risk management process\"",
        "Section 2. Responsibilities: Quality Assurance \u2014 \"Completes all required training and qualification activities prior to conducting formal risk analysis\"",
        "Section 5.1.6 \u2014 \"management shall regularly review the outputs of processes, products, services, and the quality system, and make improvements as needed, in accordance with the Management Review Process specified in XX-YYY, Management Responsibility.\"",
        "Section 5.1.7 \u2014 \"Documented records, including evidence of decisions and actions taken, shall be maintained...\"",
        "Section 5.1.8 \u2014 \"Persons performing risk management tasks have the knowledge and experience appropriate to the tasks assigned to them... Appropriate competence and training program requirements are described in QAP011, GMP Training Program.\"",
        "Section 5.11.1.6 \u2014 \"Top management of Product Development, Clinical Development, Regulatory Affairs, and QA must approve the risk management report if the benefit risk assessment is needed to justify release of the product according to established risk thresholds.\"",
        "Section 5.13.3 \u2014 \"The risk management process shall be reviewed as part of the management review following requirements in XX-YYY, Management Responsibility.\"",
        "Section 4.28 \u2014 Definition of Top Management: \"A person or group of people who directs and controls an organization at the highest level, having the power to delegate authority and provide resources within the organization.\""
      ],
      "gaps": [
        "No management review records or minutes demonstrating top-management review of the risk management process were provided.",
        "No explicit resourcing decisions or evidence of resource allocation by top management (e.g., budgets, staffing approvals).",
        "No organizational chart or documented assignment of specific competent personnel (names/roles) to risk management responsibilities.",
        "No training plan details or matrix for risk management personnel (only a reference to QAP011; the plan itself and training records are not included).",
        "No approval/signature page showing top\u2011management approval of this SOP or related policies."
      ],
      "recommendations": [
        "Provide recent Management Review records/minutes (per XX-YYY) showing top\u2011management review of the risk management process, decisions taken, and follow-up actions.",
        "Submit documented resourcing evidence (e.g., org chart with named roles for risk management, appointment letters/RACI, staffing plans, or budget allocations) to demonstrate adequate resources and assignment of competent personnel.",
        "Include the QAP011 GMP Training Program or a summarized training plan and a training matrix/records showing that personnel performing risk management have completed required training.",
        "Attach evidence of top\u2011management approval (e.g., controlled document approval page with signatures) for this SOP and/or a risk management policy statement confirming commitment.",
        "Maintain these artifacts in the Risk Management File or a linked Quality Records repository, and reference them explicitly in the SOP or Risk Management Plan."
      ],
      "requirement_id": "ISO14971-4.2-01",
      "tokens_used": 19006
    },
    {
      "status": "PASS",
      "confidence": 0.78,
      "rationale": "The SOP establishes a policy for how risk acceptability criteria are to be defined and used. It assigns ownership to management, cites regulatory and standards inputs, instructs that product-/family-specific criteria be documented in the Risk Management Plan (RMP), and includes guidance on evaluating overall residual risk. The document appears controlled and effective (dated), implying organizational approval and accessibility within the QMS. Minor inconsistencies and missing artifacts (e.g., a sample RMP reference) do not outweigh the clear presence of the policy and process.",
      "evidence": [
        "Header/Title block: \"Document Number: QAP013.01 Title: RISK MANAGEMENT PROGRAM ... Effective Date: 26Jun2024\"",
        "Section 2, Responsibilities (Functional Area Management): \"Defines and documents criteria for risk acceptability in the Risk Management Procedure. This provides a framework that ensures that criteria are based upon applicable national or regional regulations and relevant International Standards and considers available information such as the general acknowledged state of the art and known stakeholder concerns.\"",
        "Section 2, Responsibilities (Functional Area Management): \"Ensures risk management policies are established and followed\"",
        "Section 2, Responsibilities (Quality Assurance): \"Defines and documents criteria for risk acceptability in the Risk Management Plan according to the process established in this SOP.\"",
        "Section 3, References: \"21CFR820.30; ISO 14971: 2019; ISO 12971: 2020; ... ISO 62366: 2005\"",
        "Section 5.2.3.2.2: \"Top management of Product Development, Clinical Development, Regulatory Affairs and Quality Assurance establish acceptable thresholds for residual risk acceptance within this procedure.\"",
        "Section 5.2.5: \"Categories of risk and criteria for risk acceptability, in accordance with this procedure, including criteria for accepting risks when the probability of occurrence of harm cannot be estimated. The risk acceptance criteria are based on the following decisions: 5.2.5.1. The risk presented by the current standard of care; 5.2.5.2. The potential health benefits of using the combination product; 5.2.5.3. The generally acknowledged state of the art defined in recognized consensus standards\"",
        "Section 5.2.6: \"The evaluation method and criteria for acceptability for the overall residual risk, considering all the impact of all risks together, shall be clearly defined and documented in the risk management plan.\"",
        "Section 5.2.10: \"The risk management plan may be developed for a specific product or for a family of similar products, as appropriate.\"",
        "Section 5.8.1: \"For each identified hazardous situation, the applicant shall evaluate estimated risks to determine whether the risk is acceptable, using criteria for risk acceptability defined in the risk management plan.\"",
        "Section 5.9.4.3, Table 6: \"Required Action Based on Residual Risk Evaluation ... Red: Benefit-risk analysis ... Residual risk disclosure ...; Yellow: Investigate further risk controls ...; Green: Overall benefit-risk analysis within the Risk Management Report\"",
        "Section 5.10.1: \"After all risk control measures have been implemented and verified, the Applicant shall evaluate the overall residual risk ... using the method and the criteria for acceptability of the overall residual risk defined in the risk management plan.\"",
        "Section 5.1.10: \"Risk management activities shall be communicated during the product development phases as part of the design review process, and as part of the production and post\u2011production process during the commercialization phase.\"",
        "Section 5.3.5: \"The contents of the risk management file ... shall be controlled and maintained in the document management system in accordance with QAP001...\"",
        "Section 5.3.6: \"The risk management file shall be maintained in the associated combination product design history file (DHF).\"",
        "Section 1.3: \"This SOP does not define the threshold for acceptable risk (or risk index) since this threshold will change based on the intended use and expected benefit of using the combination product.\""
      ],
      "gaps": [
        "The SOP contains a minor inconsistency: Section 1.3 states the SOP does not define thresholds, while Section 5.2.3.2.2 says top management establishes acceptable thresholds within this procedure.",
        "No explicit approval signatures or approver names are shown in the provided extract; approval is inferred from the effective date and controlled document format.",
        "Standards reference lists \"ISO 12971: 2020\" instead of ISO/TR 24971:2020 (typo) despite mentioning ISO/TR 24971 elsewhere.",
        "Expected artifact linkage: No actual RMP example or template page was provided showing explicit inclusion of risk acceptability criteria referencing this policy.",
        "Stakeholder concern capture is referenced conceptually but not operationalized (e.g., no explicit mechanism described for collecting stakeholder input beyond general statements)."
      ],
      "recommendations": [
        "Clarify the location of risk acceptability thresholds to eliminate ambiguity: explicitly state that thresholds are defined and approved in the RMP per product or product family, and adjust Section 5.2.3.2.2 or Section 1.3 accordingly.",
        "Include or reference an approval/signature page (e.g., per QAP001) in the SOP to demonstrate formal approval status.",
        "Correct the reference to ISO/TR 24971:2020 in Section 3 and ensure consistency throughout the document.",
        "Provide or link to an RMP template that includes a dedicated section for risk acceptability criteria and overall residual risk acceptability method, explicitly referencing this SOP\u2019s policy and Tables 1\u20136.",
        "Add a brief, explicit statement of the risk acceptability policy (e.g., Green generally acceptable; Yellow conditionally acceptable pending further controls/benefit-risk; Red unacceptable unless justified via benefit-risk with disclosure) to improve clarity for teams.",
        "Define a practical mechanism to capture and incorporate stakeholder concerns (e.g., VOC, clinician advisory input) into risk acceptability criteria during RMP development.",
        "Ensure document accessibility is communicated (e.g., location in the eQMS and training requirements) and cross-referenced in onboarding/training materials."
      ],
      "requirement_id": "ISO14971-4.2-02",
      "tokens_used": 19998
    }
  ],
  "generated_at": "2025-09-25T17:16:59.026110"
}